Study of Efficacy of Lamotrigine in Therapy of Bronchial Asthma

NCT00153244 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether antiepileptic drug lamotrigine is effective in the treatment of chronic asthma.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Lamotrigine

Sponsors & Collaborators

  • Rea Rehabilitation Centre, Georgia

    collaborator OTHER
  • Centre of Chinese Medicine, Georgia

    lead OTHER

Principal Investigators

  • Merab Lomia, MD, PhD · Rea Rehabilitation Centre, Georgia

  • Manana Tchaia, MD · Centre of Chinese Medicine

  • Tamara Tchelidze, MD · CRO Evidence

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Completion
2003-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00153244 on ClinicalTrials.gov